eragywaqer.wordpress.com
The manufacturing of medical devices, pharmaceuticals and biotechnolog treatments has traditionally beena strength. and were founded here and grew into majorr companies beforetheir acquisitions. Codman Neurovascular, a subsidiary, said this montjh it would stop manufacturing at the Cordis plant inMiamui Lakes, shift operations to Juarez, Mexico, and lay off 159 said it would close a former Ivax plan in Doral, shift products to other plantsw and lay off 300. President June Wolfre said this is more a sign of the timese thana long-term Demand for medical products is down because more peoplwe are putting off elective surgeries and cosmetic Wolfe said.
She expects the industry to rebound in the regiobn once the economy starts turning around becaus of good training programs and skilledc workers inthe area. Bob senior VP of business retentiom and recruitmentfor , said the industry should do bettert than the general economy during the slum and rebound afterward. Some companies are still Germany-based plans to hire 50 at its Boca Ratonmanufacturinf plant. Kelly Smallridge, president of the of Palm Beacbh County, said Scripps Florida and the incoming in Jupiter are attractingbiotechnology firms, but the credit crunch has made sealing deals difficult.
“There are some projectas we thought we would close in the last year that we have put on she said. “That’s the case with any projec we’ve been courting that’s been relyingf on external financing.” Sunrise-basedf (NASDAQ: BHRT) was ready to start manufacturing MyoCell fora 390-patieng clinical trial when a lender declared $2.9 milliomn loan in default. Bioheart CEO Howard Leonhardt said in 2000 the company only had test resulte on rabbits forthe product, which uses muscle cellse to help hearts, but raised $10 million in two weeks. Now, he is havinfg a tough time raising lessthan one-third of that despite promising results in early humajn trials.
He hopes to launch a final-stage trial and nearly double its employee courgt of 30 in Sunrise tosupporty production. In the long term, Leonhardt said MyoCell couldc become a treatment for many of the 25 million heartg failurepatients worldwide. In 1986, Leonhardt founded with just two By the time he sold it to in it had550 employees. Bioheart’s board includea William P. Murphy, who founded Cordis in Miami The largest pharmaceutical manufacturer still based and producing inSoutjh Florida, 390-employee (NASDAQ: NOVN), expects local manufacturingt employment to be flat or have modest said Joe Jones, VP of corporates affairs.
“Our lead product, a transdermaol patch called Vivelle-Dot, manufactured right here in South continues to see prescription growtnh and increases in market he said. Miami Dade College is in the second year of offerinfg a biotechnology training program and stil l hears demands for skilled medicalmanufacturing workers, said Davic Paul, the program’s director. MDC has scheduled its first biosciencd career fairfor April. Paul has been fieldint inquiries for trained workers fromthe , which needds hundreds of workers for gene sequencing at its , whichh received an $80 millionj state grant. Companies that analyze DNA and make chemicals also have inquiresd to MDC aboutfinding workers.
“Notg only is it a pretty decentg job market with a number ofavailable jobs,” Paul “but these are skilled jobs and pay highefr than average for entry-level positions.” Stephen director of research for Boca Raton-based , said: “u wouldn’t be surprised if, as you see some manufacturera cut back, other companies come in and take over the He describes the medical manufacturing landscape in Sout h Florida as a cycle of birth, maturation, acquisitionj and rebirth. “A lot of people being laid off have bright ideas for their own he said.
“You’ll have a fresh run of new It is just going to be a real rockyh ride for South Florida in thenear
Nenhum comentário:
Postar um comentário